HER2-positive Breast Cancer Algorithm with Dr. Erika Hamilton

Discussing the management using the algorithm of HER 2 Neu Positive Breast Cancer - with Dr. Erika Hamilton, Director of Breast & Gynecologic Cancer Research, Sarah Cannon Research Institute.